Skin Biopsy Market Forecast To Reach $2.74 Billion By 2030: Key Growth Drivers And Industry Trends
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Skin Biopsy Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The skin biopsy market size has demonstrated robust growth in recent years. It is projected to increase from $1.86 billion in 2025 to $2.02 billion in 2026, at a compound annual growth rate (CAGR) of 8.3%. This historical expansion can be attributed to an escalation in skin cancer incidence, the proliferation of dermatology clinics, the adoption of outpatient diagnostics, the widespread availability of biopsy instruments, and enhanced awareness regarding early diagnosis.
The skin biopsy market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $2.74 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. Factors contributing to this growth during the projection period include an increase in melanoma incidents, the embrace of AI-powered diagnostics, the broadening scope of tele-dermatology, an aging global demographic, and the expansion of cosmetic dermatology services. Key developments expected within this forecast timeframe encompass the adoption of less invasive biopsy methods, a wider application of dermatological diagnostics, a preference for punch and shave biopsy techniques, a shift towards outpatient diagnostic procedures, and the integration of AI in pathology.
Get A Free Sample Report With In-Depth Market Insights:
Skin Biopsy Market Growth Backed By Core Demand Fundamentals
The skin biopsy market is anticipated to experience growth in the future, driven by increasing healthcare expenditure. This spending encompasses the total funds allocated to medical services, treatments, facilities, research, and public health initiatives aimed at maintaining or enhancing health outcomes. The heightened need for healthcare funding is a result of the growing prevalence of chronic diseases, which often require extensive and costly treatments. Elevated healthcare expenditure contributes to greater adoption of skin biopsies by improving access to advanced diagnostic technologies and expanding dermatology services. This enables prompt detection and precise diagnosis of skin disorders, thereby supporting better patient outcomes and overall healthcare efficiency. As an example, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure in 2023 rose by 5.6% in nominal terms, indicating a 0.9% increase in growth when compared to 2022. Consequently, the rising healthcare expenditure is a key factor propelling the expansion of the skin biopsy market.
Skin Biopsy Market Segment Performance And Emerging Opportunities
The skin biopsy market covered in this report is segmented –
1) By Type Of Biopsy: Excisional Biopsy, Incisional Biopsy, Punch Biopsy, Shave Biopsy
2) By Application: Dermatology, Oncology, Clinical Research
3) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Dermatology Clinics
Subsegments:
1) By Excisional Biopsy: Full-Thickness Excision, Elliptical Excision
2) By Incisional Biopsy: Wedge Biopsy, Longitudinal Biopsy, Keyhole Biopsy
3) By Punch Biopsy: 2 Millimeter (mm) Punch, 3-4 Millimeter (mm) Punch, Greater Than Or Equal To (=) 5 Millimeter (mm) Punch
4) By Shave Biopsy: Tangential Shave, Saucerization Shave, Curved Blade Shave
Skin Biopsy Market Growth Trends Reshaping The Competitive Landscape
Companies active in the skin biopsy market are concentrating on creating advanced solutions, such as semi-automatic biopsy instruments, to improve diagnostic accuracy and the caliber of tissue samples. Semi-automatic biopsy instruments are specifically designed to ensure controlled and precise tissue gathering, thereby enhancing the likelihood of an accurate diagnosis and enabling pathologists to carry out thorough testing. For instance, in May 2023, Argon Medical Devices, a US-based provider of interventional and oncology device solutions, unveiled the SuperCore Advantage Semi-Automatic Biopsy Instrument. This device delivers excellent tissue volume and is available across a full spectrum of lengths and gauge sizes to suit various clinical applications. It is a disposable, next-generation product, conceptualized with input from healthcare professionals to fulfill clinical needs. The SuperCore Advantage empowers physicians to collect more tissue with confidence, facilitates precise and reliable biopsies, and complements Argon’s current portfolio, including the BioPince Ultra Full Core Biopsy Instrument, SuperCore Semi-Automatic, Tru-Core Automatic, and Pro-Mag Ultra Biopsy Instruments. This addition bolsters Argon’s position as a prominent supplier of soft tissue biopsy devices while simultaneously improving patient outcomes.
Skin Biopsy Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the skin biopsy market are AccuTec Inc., Delasco, KAI Medical, Medline Industries, Becton Dickinson and Company, Merit Medical Systems, Cook Medical, Hologic, Olympus Corporation, KARL STORZ, Richard Wolf, ConMed, Integra LifeSciences, Paramount Surgimed, Sklar Instruments, Hu-Friedy, Aesculap, World Precision Instruments, Miltex, Integra Miltex
View The Full Skin Biopsy Market Report:
Skin Biopsy Market Regional Outlook: Where Is Opportunity Concentrated?
North America was the largest region in the skin biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the skin biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
